In prostate cancer (PrCa) study, downregulation of the β6 integrin subunit was found to significantly promote IFIT3 expression in PrCa cells and their released small extracellular vesicles (sEVs), suggesting that IFIT3 may be negatively regulated by β6 integrin. This evidence concerns the gene IFIT3 and prostate carcinoma.